Pulished Date October, 2018
ID: 428
Share on
Share on

North America Tumor Ablation Market By Technology (Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices And Other Ablation Devices) By Treatment (Surgical Ablation, Laparoscopic Ablation And Percutaneous Ablation) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis And Other Cancer), And By Region- Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023

Pulished: October, 2018
ID: 428
Pages: 135

The North America Tumor Ablation Market was worth $xxx million in 2018 and estimated to be growing at a CAGR of 11.2%, to reach $xxxmillion by 2023 Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung and liver.

Rising Prevalence of cancer is proportional to the growth of tumor ablation market. As per data published by the American Cancer Society, the incidence of cancer in United States is 300.2 per 100,000 annually. Similarly in Canada the number is somewhere around 236.6 cases.

North America Tumor ablation market is driven by key factors such as growing geriatric population, increasing number of people affected with cancer, technological advancements in the field of ablation. Increasing demand for minimally invasive cancer treatment procedures and favourable reimbursement structures coupled with rising disposable income are some of the other major factors fuelling the growth of the market. However challenges related to ablation procedures and stringent regulatory guidelines delaying product launches are restraining the market growth.

North America Tumor ablation market is segmented by technology, treatment and application. Based on technology the market is sub-segmented as Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices is the dominating segment accounting for a share of about 35% attributed to its crucial role in solid tumour removal in the body. On the basis of treatment the market is segmented as Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Surgical Procedures segment accounted for a highest share of around 37% owing to increasing prevalence of liver and breast cancers. By application North America tumor ablation market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer.

On the basis of geography North America Tumor Ablation market is segmented into United States and Canada. North America is the largest market for tumor ablation with over 33% share owing to its advanced healthcare infrastructure. Within North America, United States is the largest market due to favourable reimbursement policies and high government support while Canada is estimated to be the fastest growing region due to increasing incidence of cancer.

Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 By Technology                                           

                                5.1.1 Radiofrequency Ablation Devices                 

                                5.1.2 Microwave Ablation Devices                           

                                5.1.3 Cryoablation Devices                          

                                5.1.4 Other Ablation Devices                      

                5.2 By Treatment                                            

                                5.2.1 Surgical Ablation                   

                                5.2.2 Laparoscopic Ablation                        

                                5.2.3 Percutaneous Ablation                      

                5.3 By Application                                           

                                5.3.1 Liver Cancer                            

                                5.3.2 Breast Cancer                        

                                5.3.3 Lung Cancer                            

                                5.3.4 Prostrate Metastasis                          

                                5.3.5 Other Cancers                       

6. Geographical Analysis                                                              

                                6.1 Introduction                               

                                6.2 United States                            

                                6.3 Canada                         

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Medtronic Plc.                                           

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Angiodynamics                                         

                8.3 Mermaid Medical                                    

                8.4 HealthTronics                                            

                8.5 Galil Medical Inc.                                      

                8.6 EDAP TMS S.A.                                          

                8.7 Boston Scientific Corporation                                             

                8.8 SonaCare Medical                                    

                8.9 Misonix, Inc.                                              

                8.10 Neuwave Medical, Inc.                                       

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Tumor Ablation Market By Region, From 2018-2023 (USD Million)
  2. North America Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  3. North America Radiofrequency Ablation Devices Market By Region, From 2018-2023 (USD Million)
  4. North America Microwave Ablation Devices Market By Region, From 2018-2023 (USD Million)
  5. North America Cryoablation Devices Market By Region, From 2018-2023 (USD Million)
  6. North America other Ablation Devices Market By Region, From 2018-2023 (USD Million)
  7. North America Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  8. North America Surgical Ablation Market By Region, From 2018-2023 (USD Million)
  9. North America Laparoscopic Ablation Market By Region, From 2018-2023 (USD Million)
  10. North America Percutaneous Ablation Market By Region, From 2018-2023 (USD Million)
  11. North America Tumor Ablation Market By Application, From 2018-2023 (USD Million)
  12. North America Liver Cancer Market By Region, From 2018-2023 (USD Million)
  13. North America Breast Cancer Market By Region, From 2018-2023 (USD Million)
  14. North America Lung Cancer Market By Region, From 2018-2023 (USD Million)
  15. North America Prostrate Metastasis Market By Region, From 2018-2023 (USD Million)
  16. North America other cancer Market By Region, From 2018-2023 (USD Million)
  17. United States Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  18. United States Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  19. United States Tumor Ablation Market By Application, From 2018-2023 (USD Million)
  20. Canada Tumor Ablation Market By Technology, From 2018-2023 (USD Million)
  21. Canada Tumor Ablation Market By Treatment, From 2018-2023 (USD Million)
  22. Canada Tumor Ablation Market By Application, From 2018-2023 (USD Million)

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Request Sample